BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 4, 2021
View Archived Issues
Lysogene initiates phase I/II study of LYS-GM101 gene therapy in infantile GM1 gangliosidosis
Read More
FDA approves IND for KRAS G12C inhibitor JAB-21822
Read More
SAN-903 reduces lung inflammation and fibrosis in mouse model of IPF
Read More
First direct KRAS G12V(ON) inhibitors developed at Revolution Medicines
Read More
New model allows exploration of PHF21B gene function
Read More
Promising part A data from MOMENTUM study of SRP-5051 in DMD
Read More
Promising safety data from first dose cohort of phase I study evaluating DSG3-CAART
Read More
Shanghai HaiHe Biopharma patents BRD4 inhibitors
Read More
Janssen Biotech presents DHODH inhibitors
Read More
New IDH1 inhibitors presented by Shanghai Meton Pharmaceutical
Read More
Kallyope discloses GPR119 agonists
Read More
Avacta Life Sciences presents new PD-L1 inhibitors
Read More
Topline data presented from first cohort of phase Ib trial of RGLS-4326
Read More
BRM-421: human study data for dry eye syndrome
Read More
Novavax announces pediatric expansion of pivotal PREVENT-19 trial of NVX-CoV-2373
Read More
Ongoing TOGETHER platform study will evaluate Lambda in outpatients with COVID-19
Read More
HORNBILL phase I data reported for BI-764524
Read More
DF-6002 shows robust antitumor activity in preclinical models
Read More
Discovery and optimization of novel N-pyrimidines as IDO1 inhibitors
Read More
Administration of 5,6-DiHETE, an endogenous TRPV4 antagonist, contributes to colitis healing in mice
Read More
Mitochondrial peptide causes septic shock nosocomials, mortality
Read More
LRRK2 inhibitor DNL-151 well tolerated in healthy volunteers and patients with PD
Read More
XBiotech and INSERM collaborate on phase II/III trial of XB-2001
Read More
Vaxart reports phase I findings on oral COVID-19 vaccine VXA-CoV2-1
Read More
FDA clears IND for phase II trial of CT-868 in overweight and obese patients with type 2 diabetes
Read More
FDA approves Kloxxado for opioid overdose
Read More
Merus begins phase I/II study of MCLA-129 in NSCLC and solid tumors
Read More
PXS-5505 to enter preclinical evaluation for glioblastoma
Read More